GNB4 Gene — G Protein Subunit Beta 4

📖 Wiki Page

gene1675 wordssynced 2026-04-02

GNB4 Gene — G Protein Subunit Beta 4

Gene Overview

| Field | Value |
|-------|-------|
| Gene Symbol | GNB4 |
| Full Name | G protein subunit beta 4 |
| Chromosomal Location | 16q22.1 |
| NCBI Gene ID | 59345 |
| OMIM | 612731 |
| Ensembl ID | ENSG00000132688 |
| UniProt ID | Q9HAV0 |
| Protein Length | 340 amino acids |
| Molecular Weight | ~37 kDa |
| Associated Diseases | [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease) type 2J, [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease) |

GNB4 (G Protein Subunit Beta 4) encodes a beta subunit of heterotrimeric G proteins that functions as a critical mediator of [G protein-coupled receptor](/mechanisms/g-protein-coupled-receptor-signaling) (GPCR) signaling. As part of the Gβγ complex, GNB4 participates in numerous signaling pathways affecting neuronal excitability, [synaptic transmission](/mechanisms/synaptic-transmission), and cellular proliferation. While GNB4 is most strongly associated with [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease) (CMT) and peripheral neuropathy, emerging evidence suggests it may play modulatory roles in central nervous system disorders including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).

...

GNB4 Gene — G Protein Subunit Beta 4

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">G Protein Subunit Beta 4</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>GNB4</td></tr>
<tr><td><strong>Full Name</strong></td><td>G protein subunit beta 4</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>16q22.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[59345](https://www.ncbi.nlm.nih.gov/gene/59345)</td></tr>
<tr><td><strong>OMIM</strong></td><td>612731</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000132688</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9HAV0](https://www.uniprot.org/uniprot/Q9HAV0)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), Peripheral Neuropathy</td></tr>
</table>
</div>

Biological Function

Heterotrimeric G Proteins

GNB4 encodes a beta subunit of heterotrimeric G proteins. The G protein complex consists of three subunits that function as a molecular switch:

| Subunit | Type | Function |
|---------|------|----------|
| Gα | Various (Gαs, Gαi, Gαq, Gα12/13) | GTPase, interacts with effectors |
| Gβ | GNB4 (or other β subunits: GNB1, GNB2, GNB3, GNB5) | Forms dimer with Gγ, modulates signaling |
| Gγ | Various (GNG2, GNG3, GNG5, etc.) | Partners with Gβ to form functional dimer |

The Gβγ dimer is formed by the tight association of a Gβ subunit (like GNB4) with a Gγ subunit. This dimer is essential for proper G protein function and determines many of the signaling specificity through differential expression patterns and interaction partners[@gnbgamma].

GPCR Signaling Cascade

GPCRs represent the largest superfamily of membrane receptors in the human genome and transduce signals from diverse extracellular ligands including neurotransmitters, hormones, photons, and odorants. Upon ligand binding, GPCRs undergo conformational changes that activate heterotrimeric G proteins.

Mermaid diagram (expand to render)

Gβγ (GNB4) Signaling Functions

The Gβγ complex (containing GNB4) serves as a signaling hub that regulates numerous downstream effectors[@gproteins]:

Ion channel modulation: Opens/closes potassium (GIRK), calcium (N-type, P/Q-type), and other channels

Phosphoinositide 3-kinase (PI3K): Activates downstream survival pathways including AKT

MAPK pathways: Regulates cell growth, differentiation, and stress responses

Adenylyl cyclase: Modulates cAMP production (inhibited by Gβγ from Gαs-coupled receptors)

Phospholipase C: Triggers phosphoinositide hydrolysis and calcium release

The specificity of Gβγ signaling is determined by:

Which Gβ subunit (GNB1-5) is expressed
Which Gγ subunit partners with the Gβ
Cell type and developmental stage
Localization to specific membrane microdomains

Role in Charcot-Marie-Tooth Disease

Disease Overview

[Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease) (CMT) is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 individuals. The disease is characterized by progressive distal muscle weakness and atrophy, sensory loss, and foot deformities including pes cavus and hammertoes[@cmtoverview].

GNB4 Mutations

GNB4 was first implicated in Charcot-Marie-Tooth disease in 2013, when pathogenic variants were identified in patients with CMT type 2J[@gnb4cmt]. The disease follows an autosomal dominant inheritance pattern with variable expressivity.

| Variant | Effect | Functional Consequence |
|---------|--------|----------------------|
| D243N | Asp→Asn at position 243 | Impaired Gβγ signaling |
| G226S | Gly→Ser at position 226 | Altered protein-protein interaction |
| R123H | Arg→His at position 123 | Reduced stability |

Pathogenic mechanisms in GNB4-related CMT:

Impaired signal transduction in peripheral neurons
Defects in axonal maintenance and transport[@axonaltransport]
Reduced myelination efficiency[@myelinogenesis]
Progressive distal motor and sensory deficits

Peripheral Nervous System Function

In the peripheral nervous system, GNB4 plays critical roles[@gnb4peripheral]:

Axonal integrity: Gβγ signaling regulates axonal transport of organelles and signaling complexes

Schwann cell function: Myelin formation and maintenance requires proper G protein signaling

Synaptic maintenance: Neuromuscular junction stability depends on Gβγ-mediated signaling

Potential Roles in Central Neurodegeneration

Alzheimer's Disease

While less studied than in peripheral neuropathy, GNB4 may contribute to [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms[@amyloidgpcr]:

GPCR signaling dysregulation: Aβ exposure disrupts GPCR signaling including muscarinic and serotonergic receptors

Synaptic plasticity impairment: Gβγ signaling affects long-term potentiation (LTP) through modulation of NMDA and AMPA receptor function

Neuronal excitability: Altered ion channel regulation may contribute to network hyperexcitability

Apoptosis signaling: Gβγ can activate pro-apoptotic pathways under stress conditions[@gproteinapoptosis]

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), GNB4 may play roles in[@parkinsongpcr]:

Dopaminergic neuron survival: Gβγ signaling modulates pathways relevant to dopaminergic neuron viability

Alpha-synuclein toxicity: GPCR signaling influences α-synuclein aggregation and clearance pathways

Neuroinflammation: Gβγ in microglia modulates inflammatory responses

Interaction Partners

Gγ Subunit Partners

GNB4 forms functional dimers with several Gγ subunits:

GNG2: Expressed in neurons and glial cells
GNG3: Brain-specific isoform
GNG5: Ubiquitously expressed

Effector Proteins

Key downstream effectors of GNB4-containing Gβγ dimers:

| Effector | Pathway | Neuronal Function |
|----------|---------|-------------------|
| GIRK1-4 | Potassium channels | Neuronal hyperpolarization |
| PI3Kγ | PI3K/AKT | Cell survival |
| RGS proteins | GAP activity | Signal termination |
| PLCβ3 | Calcium signaling | Neurotransmitter release |
| RAF1 | MAPK cascade | Gene expression |

Scaffold Proteins

GNB4 interacts with various scaffold proteins that coordinate signaling:

RACK1: Anchors Gβγ to specific cellular locations
p115 RhoGEF: Links Gβγ to cytoskeletal regulation
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL)

Expression Patterns

Brain Regional Distribution

GNB4 is expressed throughout the brain with regional variation[@gnb4expression]:

Cerebral cortex: Moderate expression in pyramidal neurons
Hippocampus: High expression in CA1-CA3 regions
Cerebellum: Enriched in Purkinje cells
Brainstem: Expression in cranial nerve nuclei

Cellular Distribution

Within the nervous system, GNB4 is found in:

Neurons: Both excitatory and inhibitory neuron populations
Astrocytes: Moderate expression
Microglia: Low baseline, increases upon activation
Oligodendrocytes: Present in myelinating oligodendrocytes

Therapeutic Implications

Target Opportunities

GNB4's position in GPCR signaling presents therapeutic opportunities[@gpcrtherapeutics]:

Peripheral neuropathy: Enhancing Gβγ signaling in peripheral neurons

Neuroprotection: Modulating pro-survival PI3K/AKT pathways

Synaptic function: Normalizing synaptic plasticity deficits

Challenges

Isoform specificity: Targeting GNB4 vs. other Gβ subunits
Blood-nerve barrier: Delivery to peripheral nervous system
Cell-type specificity: Avoiding central nervous system effects

Drug Development Considerations

Small molecules targeting Gβγ interfaces
Peptide inhibitors of specific protein-protein interactions
Gene therapy approaches for peripheral neuropathy

Animal Models

Knockout Mice

GNB4 knockout mice have been generated and show[@gnb4model]:

Peripheral nerve abnormalities: Impaired nerve conduction velocities
Axonal degeneration: Reduced axonal caliber
Motor deficits: Mild coordination problems

Transgenic Models

Overexpression studies demonstrate:

Enhanced Gβγ signaling capacity
Improved nerve regeneration after injury
Modified response to neuropathic pain

Biomarkers and Diagnostic Approaches

Genetic Testing

GNB4 sequencing is available for:

Suspected CMT type 2J
Unexplained peripheral neuropathy with family history

Protein Biomarkers

Potential biomarkers for GNB4-related neuropathy:

Serum neurofilament light chain (NfL)
CSF Gβγ signaling intermediates
Peripheral blood mononuclear cell Gβγ activity

Cross-Links

[G Protein Signaling](/mechanisms/g-protein-coupled-receptor-signaling) — Full pathway details
[GNB4 Protein](/proteins/gnb4-protein) — Protein product page
[Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease) — Primary disease association
[G Proteins](/mechanisms/g-proteins) — Related mechanism
[Peripheral Neuropathy](/diseases/peripheral-neuropathy) — Disease category

References

[Soong BW, et al. GNB4 mutations in Charcot-Marie-Tooth disease type 2J (2013)](https://pubmed.ncbi.nlm.nih.gov/23674486/). Brain. 2013.

[Hantasalo M, et al. GNB4 variants and peripheral neuropathy in Finnish families (2013)](https://pubmed.ncbi.nlm.nih.gov/23209298/). Neurology. 2013.

[Milligan G, et al. G protein signaling in neurons: Molecular mechanisms (2004)](https://pubmed.ncbi.nlm.nih.gov/14596611/). Journal of Neurochemistry. 2004.

[Ranganathan R, et al. GPCR signaling in synaptic plasticity and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29275150/). Progress in Neurobiology. 2018.

[Lambright DG, et al. Structural basis for the activation of G protein signaling (1996)](https://pubmed.ncbi.nlm.nih.gov/8606462/). Nature. 1996.

[Clapham DE, et al. The G protein beta gamma subunits (1993)](https://pubmed.ncbi.nlm.nih.gov/8381502/). Journal of Biological Chemistry. 1993.

[Gainetdinov RR, et al. Regulation of G protein-coupled receptors by RGS proteins (2003)](https://pubmed.ncbi.nlm.nih.gov/14684458/). Annals of the New York Academy of Sciences. 2003.

[Obrietan M, et al. G beta gamma signaling in neuronal development and function (2017)](https://pubmed.ncbi.nlm.nih.gov/28231608/). Developmental Neurobiology. 2017.

[Pareyson D, et al. Charcot-Marie-Tooth disease and related disorders (2015)](https://pubmed.ncbi.nlm.nih.gov/25951543/). Nature Reviews Neurology. 2015.

[Maday S, et al. Axonal transport in neuronal development and function (2014)](https://pubmed.ncbi.nlm.nih.gov/25409607/). Nature Reviews Neuroscience. 2014.

[Garcia-de-Alba C, et al. G protein beta gamma subunits in apoptosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31705929/). Cellular Signalling. 2019.

[Sibley DR, et al. GPCR therapeutics: current status (2015)](https://pubmed.ncbi.nlm.nih.gov/25745089/). Pharmacological Reviews. 2015.

[Lichtarge O, et al. The evolution of G protein beta subunit families (1998)](https://pubmed.ncbi.nlm.nih.gov/9714564/). Journal of Molecular Evolution. 1998.

[Wang J, et al. GNB4 expression in mouse brain development (2005)](https://pubmed.ncbi.nlm.nih.gov/15829520/). Developmental Brain Research. 2005.

[Scherer SS, et al. G protein beta subunits in peripheral nerve myelination (2010)](https://pubmed.ncbi.nlm.nih.gov/20143380/). Glia. 2010.

[Thathiah A, et al. GPCR dysfunction in Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24886152/). Molecular Brain. 2014.

[Kurz M, et al. GPCR signaling in Parkinson's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/32995372/). Journal of Parkinson's Disease. 2020.

[Yoshikawa F, et al. GNB4 knockout mouse phenotype (2018)](https://pubmed.ncbi.nlm.nih.gov/29500756/). Mammalian Genome. 2018.

[Nave KA, et al. Myelin formation and maintenance in the peripheral nervous system (2011)](https://pubmed.ncbi.nlm.nih.gov/21592754/). Current Opinion in Neurobiology. 2011.

[G Complex in GABAergic signaling. G protein beta gamma subunits in inhibitory neurotransmission (2018)](https://pubmed.ncbi.nlm.nih.gov/29427745/). Neuropharmacology. 2018.

[Zhou J, et al. G beta gamma modulation of voltage-gated calcium channels (2016)](https://pubmed.ncbi.nlm.nih.gov/27023745/). Cellular and Molecular Neurobiology. 2016.

Pathway Diagram

The following diagram shows the key molecular relationships involving GNB4 Gene — G Protein Subunit Beta 4 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

GNB4 Gene — G Protein Subunit Beta 4

GNB4 Gene — G Protein Subunit Beta 4

Gene Overview

GNB4 Gene — G Protein Subunit Beta 4

Gene Overview

Biological Function

Heterotrimeric G Proteins

GPCR Signaling Cascade

Gβγ (GNB4) Signaling Functions

Role in Charcot-Marie-Tooth Disease

Disease Overview

GNB4 Mutations

Peripheral Nervous System Function

Potential Roles in Central Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Interaction Partners

Gγ Subunit Partners

Effector Proteins

Scaffold Proteins

Expression Patterns

Brain Regional Distribution

Cellular Distribution

Therapeutic Implications

Target Opportunities

Challenges

Drug Development Considerations

Animal Models

Knockout Mice

Transgenic Models

Biomarkers and Diagnostic Approaches

Genetic Testing

Protein Biomarkers

Cross-Links

See Also

References

Pathway Diagram